David Reese

David Reese

Chief Executive Officer at
KAI Pharmaceuticals, Inc.

Net worth: 15 M $ as of 2026-06-29

63 year
Health Technology
Commercial Services
Consumer Services

Profile

Founder of Translational Oncology Research International, Inc., David M. Reese is Executive Vice President-Research & Development at Amgen, Inc. Dr. Reese previously held the position of Director-Clinical Research at Breast Cancer International Research Group Ltd. and Director-Clinical Research at Translational Research In Oncology. He received an undergraduate degree from Harvard College and an undergraduate degree from The University of Cincinnati College of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-06 42,256 ( 0.01% ) 15 M $ 2026-06-29

David Reese active positions

CompaniesPositionStart
President -
Director/Board Member -
Chief Executive Officer -
President -
Director/Board Member 2023-04-21

Former positions of David Reese

CompaniesPositionEnd
AMGEN INC. Chief Tech/Sci/R&D Officer 2026-06-29
Founder 2004-12-31
Corporate Officer/Principal 2002-12-31
CHEMOCENTRYX, INC. Chief Executive Officer -
░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
See the detail of David Reese's experience

Training of David Reese

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

75

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services